Astrid Weins, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulosclerosis, Focal Segmental | 12 | 2023 | 357 | 2.230 |
Why?
|
| Podocytes | 13 | 2022 | 396 | 2.130 |
Why?
|
| Actinin | 6 | 2019 | 160 | 0.920 |
Why?
|
| Nephrosis, Lipoid | 2 | 2021 | 51 | 0.840 |
Why?
|
| Proteinuria | 6 | 2022 | 658 | 0.820 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2020 | 87 | 0.720 |
Why?
|
| Nephrotic Syndrome | 1 | 2022 | 389 | 0.650 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2020 | 659 | 0.590 |
Why?
|
| Microfilament Proteins | 4 | 2007 | 1152 | 0.570 |
Why?
|
| Kidney Diseases | 7 | 2022 | 2148 | 0.570 |
Why?
|
| Actins | 7 | 2019 | 2121 | 0.520 |
Why?
|
| Kidney Transplantation | 8 | 2023 | 4251 | 0.490 |
Why?
|
| Autoantibodies | 1 | 2021 | 2036 | 0.450 |
Why?
|
| Nephritis, Interstitial | 2 | 2023 | 154 | 0.390 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2020 | 173 | 0.350 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4561 | 0.310 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 1912 | 0.310 |
Why?
|
| Myocardium | 2 | 2020 | 4772 | 0.310 |
Why?
|
| Kidney Failure, Chronic | 2 | 2023 | 2535 | 0.300 |
Why?
|
| Kidney | 9 | 2023 | 7184 | 0.300 |
Why?
|
| Longevity | 1 | 2015 | 1071 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2021 | 7882 | 0.290 |
Why?
|
| Kidney Glomerulus | 6 | 2021 | 697 | 0.280 |
Why?
|
| TRPC Cation Channels | 2 | 2017 | 121 | 0.260 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2023 | 42 | 0.230 |
Why?
|
| Apolipoproteins A | 1 | 2023 | 94 | 0.230 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3690 | 0.230 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2023 | 67 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 4463 | 0.220 |
Why?
|
| Indenes | 1 | 2021 | 57 | 0.180 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 1968 | 0.180 |
Why?
|
| Point Mutation | 1 | 2005 | 1624 | 0.180 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 270 | 0.180 |
Why?
|
| Heptanes | 1 | 2019 | 8 | 0.180 |
Why?
|
| Ubiquinone | 1 | 2021 | 188 | 0.170 |
Why?
|
| Glomerulonephritis | 2 | 2014 | 372 | 0.170 |
Why?
|
| Biopsy | 6 | 2021 | 6755 | 0.170 |
Why?
|
| Ataxia | 1 | 2021 | 304 | 0.160 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 201 | 0.160 |
Why?
|
| Muscle Weakness | 1 | 2021 | 413 | 0.160 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 416 | 0.150 |
Why?
|
| Organoids | 2 | 2022 | 701 | 0.150 |
Why?
|
| Hypertension, Renal | 1 | 2017 | 177 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 320 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 2200 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2023 | 796 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2001 | 1536 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.140 |
Why?
|
| Immunoconjugates | 2 | 2014 | 901 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 995 | 0.140 |
Why?
|
| Indazoles | 1 | 2017 | 290 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2001 | 1158 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1537 | 0.130 |
Why?
|
| Mice, Knockout | 7 | 2018 | 14561 | 0.120 |
Why?
|
| Fluorocarbons | 1 | 2019 | 452 | 0.120 |
Why?
|
| Nanomedicine | 1 | 2017 | 304 | 0.120 |
Why?
|
| Albuminuria | 2 | 2019 | 681 | 0.120 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.120 |
Why?
|
| Glomerular Basement Membrane | 1 | 2013 | 33 | 0.120 |
Why?
|
| Phosphatidylserines | 1 | 2015 | 193 | 0.120 |
Why?
|
| PAX2 Transcription Factor | 1 | 2014 | 80 | 0.120 |
Why?
|
| Pyrazoles | 2 | 2022 | 1972 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2018 | 723 | 0.120 |
Why?
|
| Benzamides | 1 | 2019 | 1379 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1525 | 0.120 |
Why?
|
| Graft Rejection | 4 | 2023 | 4397 | 0.110 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2013 | 86 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3486 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 2917 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2013 | 198 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1793 | 0.110 |
Why?
|
| Palmitic Acid | 1 | 2013 | 154 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2001 | 2969 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 712 | 0.100 |
Why?
|
| Microscopy | 1 | 2017 | 902 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 241 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2019 | 1736 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1486 | 0.100 |
Why?
|
| Humans | 38 | 2023 | 744366 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 2043 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2010 | 57 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2019 | 2441 | 0.090 |
Why?
|
| Mutation | 7 | 2023 | 29786 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2017 | 828 | 0.090 |
Why?
|
| Gelsolin | 1 | 2010 | 190 | 0.090 |
Why?
|
| Protein Binding | 6 | 2019 | 9384 | 0.090 |
Why?
|
| Dynamins | 1 | 2010 | 152 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2015 | 1539 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2005 | 1264 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
| Consanguinity | 1 | 2011 | 454 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2008 | 626 | 0.090 |
Why?
|
| Mice | 12 | 2021 | 81201 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2013 | 1185 | 0.080 |
Why?
|
| Homozygote | 2 | 2011 | 1787 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 972 | 0.080 |
Why?
|
| HEK293 Cells | 4 | 2021 | 4208 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 749 | 0.080 |
Why?
|
| Amino Acid Sequence | 6 | 2015 | 13814 | 0.080 |
Why?
|
| Animals | 15 | 2021 | 168768 | 0.080 |
Why?
|
| Binding Sites | 3 | 2008 | 6111 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2023 | 1382 | 0.070 |
Why?
|
| Cytokines | 1 | 2022 | 7323 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 18111 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1335 | 0.070 |
Why?
|
| Pedigree | 3 | 2014 | 4642 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 3773 | 0.070 |
Why?
|
| Male | 15 | 2021 | 350115 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 2839 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9445 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 2949 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2017 | 237 | 0.060 |
Why?
|
| Disease Progression | 3 | 2018 | 13286 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 6386 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2015 | 4162 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 40559 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2014 | 5451 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3203 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1865 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 1723 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2020 | 2646 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 17446 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 3848 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2023 | 121 | 0.050 |
Why?
|
| HLA-DQ Antigens | 1 | 2023 | 210 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18034 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2007 | 1169 | 0.050 |
Why?
|
| Thiazolidines | 1 | 2001 | 74 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4459 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2001 | 80 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 182 | 0.050 |
Why?
|
| Female | 13 | 2021 | 380193 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2014 | 10483 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2022 | 244 | 0.050 |
Why?
|
| Heating | 1 | 2001 | 97 | 0.050 |
Why?
|
| Azetidines | 1 | 2022 | 142 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2021 | 89 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2001 | 165 | 0.050 |
Why?
|
| Static Electricity | 2 | 2014 | 263 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.050 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Probability | 1 | 2005 | 2506 | 0.040 |
Why?
|
| Fibronectins | 1 | 2023 | 726 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 21833 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Kinetics | 1 | 2007 | 6476 | 0.040 |
Why?
|
| Clone Cells | 1 | 2023 | 1692 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2013 | 19233 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9724 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 41005 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15297 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2023 | 679 | 0.040 |
Why?
|
| Purines | 1 | 2022 | 594 | 0.040 |
Why?
|
| Sulfonamides | 2 | 2022 | 1940 | 0.040 |
Why?
|
| Crystallization | 1 | 2019 | 525 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4805 | 0.040 |
Why?
|
| Hypokalemia | 1 | 2019 | 153 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 853 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 4153 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 1475 | 0.040 |
Why?
|
| Rats, Inbred Dahl | 1 | 2017 | 35 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 72 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13104 | 0.040 |
Why?
|
| Oxides | 1 | 2019 | 405 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2019 | 374 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 934 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 399 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2018 | 169 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 234 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2017 | 198 | 0.040 |
Why?
|
| Paraproteinemias | 1 | 2019 | 246 | 0.040 |
Why?
|
| Child | 3 | 2021 | 77709 | 0.040 |
Why?
|
| Microspheres | 1 | 2019 | 777 | 0.040 |
Why?
|
| Autopsy | 1 | 2020 | 1020 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3505 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 16000 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1837 | 0.030 |
Why?
|
| Protein Transport | 1 | 2001 | 1988 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 9584 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57776 | 0.030 |
Why?
|
| Mucin-1 | 1 | 2019 | 543 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2023 | 3207 | 0.030 |
Why?
|
| Thiazoles | 1 | 2001 | 1483 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 1919 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2242 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 214052 | 0.030 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2013 | 39 | 0.030 |
Why?
|
| Protamines | 1 | 2013 | 106 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 86 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11486 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2014 | 4010 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2005 | 3444 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2013 | 119 | 0.030 |
Why?
|
| Benzylamines | 1 | 2013 | 223 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 1951 | 0.030 |
Why?
|
| Graft Survival | 1 | 2023 | 3737 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12073 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 194 | 0.030 |
Why?
|
| Protective Agents | 1 | 2013 | 156 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9735 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 720 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 878 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 4925 | 0.030 |
Why?
|
| Benzoates | 1 | 2013 | 217 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 2383 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 1800 | 0.020 |
Why?
|
| Iron | 1 | 2019 | 1774 | 0.020 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 261 | 0.020 |
Why?
|
| Genotype | 1 | 2005 | 12952 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2014 | 1202 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2890 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14723 | 0.020 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2014 | 427 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2166 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1790 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2219 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 24252 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2182 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 721 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 19905 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1656 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7798 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3617 | 0.020 |
Why?
|
| Middle Aged | 5 | 2023 | 213390 | 0.020 |
Why?
|
| Breast | 1 | 2017 | 1970 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1012 | 0.020 |
Why?
|
| Viscosity | 1 | 2008 | 328 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2014 | 6194 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2013 | 942 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2184 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1707 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2007 | 182 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5717 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20952 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3270 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2007 | 420 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1539 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3702 | 0.020 |
Why?
|
| Elasticity | 1 | 2008 | 657 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2001 | 13035 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5300 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 984 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23404 | 0.020 |
Why?
|
| Endocytosis | 1 | 2010 | 985 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 2453 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4185 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4222 | 0.020 |
Why?
|
| Inflammation | 2 | 2015 | 10637 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2566 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 2596 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1247 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12961 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 3130 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4894 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12262 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2134 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 2012 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 1081 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12797 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16367 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3707 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11525 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
| Heterozygote | 1 | 2008 | 2804 | 0.010 |
Why?
|
| Adolescent | 3 | 2014 | 85779 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5660 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 163288 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16690 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 56429 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13693 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15520 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77460 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63107 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39052 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 53290 | 0.010 |
Why?
|